- Home
- NCRA vs RDHL Comparison
NCRA vs RDHL Comparison
Compare NCRA & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCRA
- RDHL
- Stock Information
- Founded
- NCRA 2002
- RDHL 2009
- Country
- NCRA Taiwan
- RDHL Israel
- Employees
- NCRA N/A
- RDHL N/A
- Industry
- NCRA Farming/Seeds/Milling
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- NCRA Consumer Staples
- RDHL Health Care
- Exchange
- NCRA Nasdaq
- RDHL Nasdaq
- Market Cap
- NCRA 14.4M
- RDHL 3.8M
- IPO Year
- NCRA N/A
- RDHL N/A
- Fundamental
- Price
- NCRA $1.01
- RDHL $1.91
- Analyst Decision
- NCRA
- RDHL
- Analyst Count
- NCRA 0
- RDHL 0
- Target Price
- NCRA N/A
- RDHL N/A
- AVG Volume (30 Days)
- NCRA 54.2K
- RDHL 17.8K
- Earning Date
- NCRA 08-13-2025
- RDHL 04-10-2025
- Dividend Yield
- NCRA N/A
- RDHL N/A
- EPS Growth
- NCRA N/A
- RDHL N/A
- EPS
- NCRA N/A
- RDHL N/A
- Revenue
- NCRA $16,647,379.00
- RDHL $8,042,999.00
- Revenue This Year
- NCRA N/A
- RDHL $381.91
- Revenue Next Year
- NCRA N/A
- RDHL N/A
- P/E Ratio
- NCRA N/A
- RDHL N/A
- Revenue Growth
- NCRA N/A
- RDHL 23.17
- 52 Week Low
- NCRA $0.70
- RDHL $1.71
- 52 Week High
- NCRA $2.09
- RDHL $20.28
- Technical
- Relative Strength Index (RSI)
- NCRA 50.60
- RDHL 43.03
- Support Level
- NCRA $0.87
- RDHL $1.72
- Resistance Level
- NCRA $1.05
- RDHL $2.08
- Average True Range (ATR)
- NCRA 0.07
- RDHL 0.09
- MACD
- NCRA -0.00
- RDHL 0.01
- Stochastic Oscillator
- NCRA 65.79
- RDHL 27.78
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.